## EMN: Eastman Chemical Company - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -0.3% below STRENGTH zone (4.0-10.0%); PEG 3.59 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (53% of avg), momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($56.99)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Eastman Chemical Co. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251202T172800 | Neutral | Relevance: 99%
- Eastman Chemical Co. (EMN) stock declined by 1.55% on Tuesday, closing at $60.99. This underperformance occurred despite a generally positive day for the broader stock market, with both the S&P 500 Index and the Dow Jones Industrial Average posting gains. The decrease marked the second consecutive day of losses for the company's stock.

**2. Eastman Chemical (EMN): Assessing Value Potential After Recent Share Price Recovery**
- Source: Simply Wall Street | 20251202T193238 | Somewhat-Bullish | Relevance: 98%
- This article assesses the value potential of Eastman Chemical (EMN) after a recent share price recovery, noting its 1-year total shareholder return of -37.3%. Despite challenges, the company is estimated to be 14.9% undervalued, with a fair value of $72.76 compared to its current price of $61.95, driven by growth in sustainable materials and stable contracts. Investors are encouraged to consider the potential for recovery and delve into analyst forecasts and identified risks.

**3. Eastman Chemical Company $EMN Shares Purchased by Charles Schwab Investment Management Inc.**
- Source: MarketBeat | 20251130T091109 | Neutral | Relevance: 98%
- Charles Schwab Investment Management Inc. increased its stake in Eastman Chemical Company (NYSE:EMN) by 3.4% in the second quarter, bringing its total holdings to 1,179,608 shares. This purchase contributes to the 83.65% institutional ownership of the company. Despite missing quarterly earnings and revenue expectations and a lowered FY2025 guidance, analysts maintain a "Moderate Buy" rating with an average price target of $78.62 for the stock.

**4. Steward Partners Investment Advisory LLC Has $2.35 Million Stock Holdings in Eastman Chemical Company $EMN**
- Source: MarketBeat | 20251130T110219 | Neutral | Relevance: 98%
- Steward Partners Investment Advisory LLC has reduced its stake in Eastman Chemical Company (NYSE:EMN) by 31.0% to 31,522 shares, valued at $2.35 million. This comes as Eastman Chemical missed Q3 earnings and revenue expectations and provided lower-than-analyst guidance for FY2025 EPS. The stock is currently trading near $61, with a moderate buy consensus rating and an average target price of $78.62 from analysts.

**5. Eastman Chemical (EMN): Assessing Value Potential After Recent Share Price Recovery**
- Source: Simply Wall Street | 20251202T233619 | Somewhat-Bullish | Relevance: 98%
- Eastman Chemical's (EMN) shares have seen recent movement, leading to questions about whether the current price reflects its fundamentals. The stock is considered 14.9% undervalued according to Simply Wall St's analysis, with a fair value of $72.76 compared to its last close of $61.95. The article discusses potential growth drivers in sustainable materials and highlights key risks and investment considerations for the company.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | Evercore ISI Gr | $70 | $75 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | Evercore ISI Gr | main | In-Line |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.08M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.2%)
- Blackrock Inc.: 7.0% (+0.9%)
- State Street Corpora: 5.0% (+24.3%)
- Capital Research Glo: 3.7% (-1.0%)
- Dimensional Fund Adv: 3.5% (+14.4%)

### Key Risks

1. Valuation risk: PEG 3.6x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 17.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.59 signals overvaluation risk, limited margin of safety. Forward P/E 9.7x attractive for 15% earnings growth. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.5B |
| Beta | 1.25 |
| 52W Range | $56.11 - $103.82 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.59 |
| Forward P/E | 9.7 |
| Current P/E | 11.1 |
| YoY Growth | 14.6% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 1.8% to -0.3% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.3pp (needs >4.0% for momentum thesis). Below SMA200 (0.82x), long-term trend not supportive. RSI neutral at 51. Volume at 53% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.33% (CS: 56) | Neutral |
| RSI_14 | 51.4 | Neutral |
| MACD Histogram | 0.41 | Bullish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 0.997x | Below |
| vs SMA200 | 0.822x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $60.99
- **Stop Loss:** $56.99 (6.6% risk)
- **Target:** $64.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 250
- **Position Value:** $15,247.50
- **Portfolio %:** 15.25%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $0.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.14 | -2.2% |
| 2025Q2 | $1.75 | $1.60 | -8.7% |
| 2025Q1 | $1.89 | $1.91 | +1.2% |
| 2024Q4 | $1.57 | $1.87 | +18.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*